Literature DB >> 1432999

Cyclosporine and chloroquine synergistically inhibit the interferon-gamma production by CD4 positive and CD8 positive synovial T cell clones derived from a patient with rheumatoid arthritis.

R B Landewé1, A M Miltenburg, F C Breedveld, M R Daha, B A Dijkmans.   

Abstract

OBJECTIVE: To investigate synergistic interaction between cyclosporine (Cy) and chloroquine (Chl) in an in vitro system, with regard to interferon-gamma (IFN) production by OKT3 activated T cell clones.
METHODS: CD4+ and CD8+ T cell clones, derived from synovial tissue of a patient with rheumatoid arthritis (RA) were activated with plastic coated OKT3 monoclonal antibody in the presence or absence of various concentrations of Cy, Chl and their combinations. After 24 h of incubation the supernatants were assayed for IFN by ELISA:
RESULTS: Cy as well as Chl were able to completely inhibit in a concentration dependent fashion the IFN production by CD4+ and CD8+ T cell clones. Combinations of Cy and Chl, which in themselves give minor inhibition of IFN production, were able to inhibit in a synergistically enhanced fashion the production of IFN by these clones. The synergy was formally proven by the construction of isoboles. This synergy was most pronounced when drug concentrations were used which individually gave minor inhibition of IFN production.
CONCLUSION: We conclude that the results of our in vitro experiments may give rise to further investigation of the promising combination of Cy and Chl in the treatment of RA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1432999

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Combination therapy with cyclosporin in rheumatoid arthritis.

Authors:  D E Yocum
Journal:  Drugs       Date:  1995       Impact factor: 9.546

2.  Anti-inflammatory activity of chloroquine and amodiaquine through p21-mediated suppression of T cell proliferation and Th1 cell differentiation.

Authors:  Sera Oh; Ji Hyun Shin; Eun Jung Jang; Hee Yeon Won; Hyo Kyeong Kim; Mi-Gyeong Jeong; Kwang Soo Kim; Eun Sook Hwang
Journal:  Biochem Biophys Res Commun       Date:  2016-04-22       Impact factor: 3.575

Review 3.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

4.  Chloroquine inhibits T cell proliferation by interfering with IL-2 production and responsiveness.

Authors:  R B Landewé; A M Miltenburg; M J Verdonk; C L Verweij; F C Breedveld; M R Daha; B A Dijkmans
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

5.  Plasmodium falciparum infection of the placenta affects newborn immune responses.

Authors:  J Ismaili; M van der Sande; M J Holland; I Sambou; S Keita; C Allsopp; M O Ota; K P W J McAdam; M Pinder
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

6.  An open, randomized comparison study of cyclosporine A, cyclosporine A + methotrexate and cyclosporine A + hydroxychloroquine in the treatment of early severe rheumatoid arthritis.

Authors:  Piercarlo Sarzi-Puttini; Enzo D'Ingianna; Mario Fumagalli; Magda Scarpellini; Tania Fiorini; Enrico Luigi Chérié-Lignière; Benedetta Panni; Franco Fiorentini; Vincenzo Corbelli; Nebiat Belai Beyene; Claudio Mastaglio; Carlo Severi; Maurizio Locati; Marco Cazzola; Guido Menozzi; Giuseppe Monti; Francesco Saccardo; Giuseppina Alfieri; Fabiola Atzeni
Journal:  Rheumatol Int       Date:  2003-10-07       Impact factor: 2.631

Review 7.  New concepts in antimalarial use and mode of action in dermatology.

Authors:  Sunil Kalia; Jan P Dutz
Journal:  Dermatol Ther       Date:  2007 Jul-Aug       Impact factor: 2.851

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.